Abstract
Chlorpromazine is a phenothiazine with a structure similar to that of methylene blue. Since methylene blue is a well known inhibitor of nitric oxideinduced cyclic GMP accumulation, we investigated whether chlorpromazine had the same effect. Cyclic GMP accumulation, induced in a mouse teratocarcinoma cell line (P19) by sodium nitroprusside (a nitric oxide releasing agent), was inhibited by both methylene blue (IC50 0.34µM) and chlorpromazine (IC50 35µM). Chlorpromazine's action was probably directed specifically at soluble guanylate cyclase, since the drug had no effect on ADP-ribosylation in rat hippocampus, another nitric oxide-affected, but cGMP-independent event.
Similar content being viewed by others
Abbreviations
- SNP:
-
sodium nitroprusside
- NO:
-
nitric oxide
- cGMP:
-
cyclic GMP
- cAMP:
-
cyclic AMP
References
Testa R, Abbiati G, Ceserani R, Restelli G, Vanasia A, Barone D, et al. Profile ofin vitro binding affinities of neuroleptics at different rat brain receptor: cluster analysis comparison with pharmacological and clinical profiles. Pharm Res 1989;6:571–7.
Gadina M, Bertini R, Mengozzi M, Zandalasini M, Mantovani A, Ghezzi P. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock. J Exp Med 1991;173:1305–10.
Rainteau D, Wolf C, Bereziat G, Polonowski J. Binding of a spin-labelled chlorpromazine analogue to calmodulin. Biochem J 1984;221:659–63.
Roufogalis BD. Phenothiazine antagonism of calmodulin: a structurally non-specific interaction. Biochem Biophys Res Commun 1981;98:607–13.
Vadas P. Stefansky E, Pruzanski W. Potential therapeutic efficacy of inhibitors of phospholipase A2 in septic shock. Agents Actions 1986;19:194–202.
Mason RP, Chognell CF. Free radicals in pharmacology and toxicology. Selected topics. Pharmacol Rev 1982;33:189–211.
Vazquez A, Tudela J, Varon R, Garcia-Canovas F. A kinetic study of the generation and decomposition of some phenothiazine free radicals formed during enzymatic oxidation of phenothiazines by peroxidase-hydrogen peroxide. Biochem Pharmacol 1992;44:889–94.
Palacios M, Padron J, Glaria L, Rojas A, Delgado R, Knowles R, et al. Chlorpromazine inhibits both the constitutive nitric oxide synthase and the induction of nitric oxide synthase after LPS challenge. Biochem Biophys Res Commun 1993;196:280–6.
Martin W, Villani G, Jothianandan D, Furchgott F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in rabbit aorta. J Pharmacol Exp Ther 1985;232(3):708–16.
Ignarro LJ, Gruetter CA. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involment of S-nitrosothiols. Biochim Biophys Acta 1980;631:221–31.
Vezzani A, Sparvoli S, Rizzi M, Zinetti M, Fratelli M. Changes in the ADP-ribosylation status of some hippocampal proteins are linked to kindling progression. Neuroreport 1994;5:1217–20.
Brune B, Lapetina EG. Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J Biol Chem 1989;264:8455–8.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with a folin phenol reagent. J Biol Chem 1951;193:265–75.
De Lean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978;235:E97–102.
Nishikawa M, Kanamori M, Hidaka H. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent, molsidomine and metabolites. J Pharmacol Exp Ther 1982;220:183–90.
Gerzer R, Karrenbrock B, Siess W, Heim JM. Direct comparison of the effects of nitroprusside, SIN-1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity. Thromb Res 1992;52:11–21.
Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109–42.
Currie SH, Marshall JHL, Davis JM, Janowsky DS. Chlorpromazine plasma levels and effects. Arch Gen Psychiat 1970;22:289–96.
Shibanoki S, Gotoh Y, Ishikawa K. Determination of chlor-promazine in the blood and brain of mice by high performance liquid chromatography combined with electrochemical detection. Japan J Pharmacol 1984;35:169–74.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fratelli, M., Delgado, R., Zinetti, M. et al. Chlorpromazine inhibits nitric oxide-mediated increase in intracellular cGMP in a mouse teratocarcinoma cell line. Inflamm Res 44, 287–290 (1995). https://doi.org/10.1007/BF02032570
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02032570